These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21451962)
1. Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models. Xu XS; Wang H; Vermeulen A J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):353-67. PubMed ID: 21451962 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic Models of Indirect Effects and Irreversible Inactivation with Turnover: Applicability to Mechanism-Based Modeling of Gene Silencing and Targeted Protein Degradation. Wang AF; Ayyar VS J Pharm Sci; 2024 Jan; 113(1):191-201. PubMed ID: 37884193 [TBL] [Abstract][Full Text] [Related]
3. A fast method for testing covariates in population PK/PD Models. Khandelwal A; Harling K; Jonsson EN; Hooker AC; Karlsson MO AAPS J; 2011 Sep; 13(3):464-72. PubMed ID: 21725709 [TBL] [Abstract][Full Text] [Related]
7. Using pharmacokinetic/pharmacodynamic modelling in safety pharmacology to better define safety margins: a regional workshop of the Safety Pharmacology Society. Cavero I Expert Opin Drug Saf; 2007 Jul; 6(4):465-71. PubMed ID: 17688390 [TBL] [Abstract][Full Text] [Related]
8. Target-mediated drug disposition model: relationships with indirect response models and application to population PK-PD analysis. Gibiansky L; Gibiansky E J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):341-51. PubMed ID: 19578985 [TBL] [Abstract][Full Text] [Related]
11. Latent variable indirect response modeling of categorical endpoints representing change from baseline. Hu C; Xu Z; Mendelsohn AM; Zhou H J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):81-91. PubMed ID: 23275019 [TBL] [Abstract][Full Text] [Related]
12. Population PK/PD analysis of metformin using the signal transduction model. Chae JW; Baek IH; Lee BY; Cho SK; Kwon KI Br J Clin Pharmacol; 2012 Nov; 74(5):815-23. PubMed ID: 22380769 [TBL] [Abstract][Full Text] [Related]
13. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development. Gieschke R; Steimer JL Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091 [TBL] [Abstract][Full Text] [Related]
14. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models. Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234 [TBL] [Abstract][Full Text] [Related]
15. Nonlinear dynamics and chaos theory: concepts and applications relevant to pharmacodynamics. Dokoumetzidis A; Iliadis A; Macheras P Pharm Res; 2001 Apr; 18(4):415-26. PubMed ID: 11451026 [TBL] [Abstract][Full Text] [Related]